Contact info is in my profile.
We'll get you access ASAP.
I'll be in touch shortly.
Thank you!
http://matt.might.net/articles/my-sons-killer/#full
N-Glycanase 1 plays an important role in deglycosylating misfolded proteins, allowing them to be recycled into their constituent amino acids.
Bertrand's cells appear to be accumulating misfolded glycoproteins.
And I went back to my own research notes. And basically, even if you can't yet fix the defect, you can probably improve the cell ph balance and salt/mineral balance to reduce the incidence of misfolds. Since the issue here is that Bertrand's cells cannot take out the garbage, preventing the accumulation of garbage would help reduce symptoms. (And this is the essence of how I have reversed a lot of my symptoms: I initially thought I would be on high levels of supplements for life but correcting the cell chemistry has put a stop to the "normal progression of CF" and maintaining good health has turned out to be way easier than the battle to get here. YMMV, and probably will. For Bertrand, this is more of a stop-gap measure.)
Anyway, I thought I would toss that out there as something you might consider looking at -- as something that might get immediate therapeutic results, well before the FDA etc will ever approve anything likely to fix the genes.
We'd been considering N-acetyl-dideoxy-nojirimycin (2-ADN) to inhibit a different enzyme related to NGLY1. (I can't discuss more publicly since the research is unpublished, but would be happy to discuss over email.)
Can you explain a little more about how an inhibitor for NGLY1 could rescue the frame-shifted (non-nonsense) variant?
Also, on re-reading the description of NGLY1 (it's been 2 years) I realized that an acetyl-nojirimycin might be a better choice! Looks like my intuition was correct.
Relevant research on a (beta-) glycosidase (but presumably the active site structure and thus the inhibitory mechanism of nojirimycin should be similar):
http://www.pnas.org/content/99/24/15428.short
Also I had a short discussion with Dr. Freeze about his results showing that flooding with mannose (not therapeutically viable) improves activity, mannose is a weak NGLY1 inhibitor.
Also Mz: I was the biologist that responded to your query!